We are live on ! Find out more
DBIA

Dumont & Blake Investment Advisors Portfolio holdings

AUM $445M
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+31.98%
3 Year Est. Return
+78.27%
5 Year Est. Return
+88.91%
10 Year Est. Return
+293.66%
AUM
$384M
AUM Growth
+$33.9M
Cap. Flow
+$3.91M
Cap. Flow %
1.02%
Top 10 Hldgs %
34.88%
Holding
214
New
5
Increased
119
Reduced
55
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 13.03%
2 Financials 8.04%
3 Consumer Discretionary 7.83%
4 Healthcare 6.94%
5 Industrials 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
176
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$245K 0.06%
2,816
DG icon
177
Dollar General
DG
$27.9B
$236K 0.06%
1,000
DRI icon
178
Darden Restaurants
DRI
$24.4B
$233K 0.06%
1,549
-13
-0.8% -$1.92K
SDIV icon
179
Global X SuperDividend ETF
SDIV
$1.22B
$224K 0.06%
6,075
CTVA icon
180
Corteva
CTVA
$51.3B
$221K 0.06%
+4,673
New +$213K
OXY icon
181
Occidental Petroleum
OXY
$55.9B
$220K 0.06%
7,582
+350
+5% +$11K
TDS icon
182
Telephone and Data Systems
TDS
$3.75B
$220K 0.06%
10,907
+74
+0.7% +$1.44K
BND icon
183
Vanguard Total Bond Market
BND
$161B
$213K 0.06%
2,515
-145
-5% -$12.3K
PRAA icon
184
PRA Group
PRAA
$755M
$211K 0.06%
+4,200
New +$187K
CCL icon
185
CALL
Carnival Corporation Ltd
CCL
$39.7B
$205K 0.05%
10,200
MS icon
186
Morgan Stanley
MS
$340B
$203K 0.05%
2,072
-50
-2% -$4.98K
HBI
187
DELISTED
Hanesbrands
HBI
$201K 0.05%
12,003
+7
+0.1% +$119
NEA icon
188
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.42B
$167K 0.04%
10,712
ORMP icon
189
Oramed Pharmaceuticals
ORMP
$179M
$118K 0.03%
8,250
+200
+2% +$4.18K
MS icon
190
PUT
Morgan Stanley
MS
$340B
$98K 0.03%
1,000
AMRN
191
Amarin Corp
AMRN
$303M
$74K 0.02%
1,100
ORMP icon
192
PUT
Oramed Pharmaceuticals
ORMP
$179M
$69K 0.02%
+4,800
New +$100K
DHF
193
BNY Mellon High Yield Strategies Fund
DHF
$172M
$60K 0.02%
19,585
+5,015
+34% +$16.1K
CCL icon
194
Carnival Corporation Ltd
CCL
$39.7B
$50K 0.01%
2,480
+300
+14% +$6.42K
HBI
195
CALL
DELISTED
Hanesbrands
HBI
$33K 0.01%
2,000
VGZ icon
196
Vista Gold
VGZ
$308M
$21K 0.01%
30,000
VECO icon
197
CALL
Veeco
VECO
$3.23B
$20K 0.01%
700
+200
+40% +$5.1K
ORMP icon
198
CALL
Oramed Pharmaceuticals
ORMP
$179M
$4K ﹤0.01%
300
-6,000
-95% -$125K
IP icon
199
International Paper
IP
$22B
-4,188
Closed -$222K
NCLH icon
200
Norwegian Cruise Line
NCLH
$8.84B
-8,385
Closed -$224K

Similar funds

Dumont & Blake Investment Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Dumont & Blake Investment Advisors held 214 positions worth $384M, up 9.7% from $350M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.2%. Dumont & Blake Investment Advisors opened 5 new positions and exited 4, leaving the 214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Dumont & Blake Investment Advisors's largest Q4 2021 buy was Filana Therapeutics: 6,000 shares worth $262K.
  • Dumont & Blake Investment Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $397K increase.
  • Dumont & Blake Investment Advisors's biggest Q4 2021 reduction was Tesla, cutting an estimated $302K.
  • Dumont & Blake Investment Advisors fully exited Take-Two Interactive in Q4 2021, selling an estimated $616K.
  • Dumont & Blake Investment Advisors's ten largest holdings make up 35% of its $384M portfolio in Q4 2021.
  • Dumont & Blake Investment Advisors opened 5 new positions and closed 4 in Q4 2021.
  • Dumont & Blake Investment Advisors's portfolio value rose 9.7% quarter-over-quarter to $384M.

Based on Dumont & Blake Investment Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.